乌鸦传媒

One negative trial in the phase III PROMIS program blamed squarely on the COVID-19 pandemic

"We should be cautious about using drugs off-label," investigator says

They'll "still have that ball and chain, but maybe we've lightened it a little bit," says expert

Investigational depemokimab succeeds in patients with high blood eosinophil count

An immediate appointment to a smoking cessation clinic shows benefit versus usual care

Plus: idrevloride for primary ciliary dyskinesia and ultrasound for pulmonary embolism

Most were able to reduce doses without increase in symptoms, exacerbations, trial finds

Along with self-monitoring, treatment limited altitude-related adverse health effects vs placebo

But patients on intervention had better asthma control at study end

Meta-analysis found mixed results for a drug that's about to go before an FDA panel

Calcineurin inhibitor significantly reduced CLAD rates in Scandinavian trial

Fish oil and high-dose vitamin D led to 38% and 40% reduced risks of croup in kids under age 3

Deaths in hospitalized patients significantly higher with oral brensocatib, trial finds

Good option for patients who can't have surgery or radiotherapy, surgeon says